Jonathan Weeks, MD. Part One

Medically Assisted Treatment for Opioid Use Disorder Part One

Evaluation and Credit: https://www.surveymonkey.com/r/MedChat5A

Target Audience

This activity is targeted toward internal medicine, family medicine and other specialties that treat patients with chronic pain.

Statement of Need

In 2017, overdose fatalities in Kentucky rose by 11% and Jefferson County had the most overdose deaths. It is critical for physicians and providers to be aware of the prevalence of illegal drugs and understand this culture - as legal prescribing guidelines / availability continues to be more restrictive and addicted patients may seek their "high" from illegal sources.

Objectives

At the conclusion of this offering, the participant will be able to:

• Define medically assisted therapy (MAT) for opioid addiction.
• Identify the FDA-approved medications for opioid use disorder.
• Understand the indications, benefits and limitations of MAT; including the pregnant patient.
• Discuss the psychological effects of opiate withdrawal.

Moderator
James Jennings, M.D.
Executive Medical Director, Adult Primary Care Director, Provider Wellbeing
Norton Healthcare

Speaker
Jonathan W. Weeks, M.D.
Maternal-Fetal Medicine
Norton Children’s Maternal-Fetal Medicine

Moderator, Speaker and Planner Disclosures

The moderator, speaker and planners for this activity have no potential or actual conflicts of interest to disclose.

 

Commercial Support

This activity is supported in part with a grant from Cardinal Health.

 

Physician Credits
American Medical Association

Accreditation

Norton Healthcare is accredited by the Kentucky Medical Association to provide continuing medical education for physicians.

Designation
Norton Healthcare designates this enduring material for a maximum of .50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

HB1 / Prescribing Controlled Substances
The Kentucky Board of Medical Licensure has approved the podcast Medically Assisted Treatment for Opioid Use

Disorder - Part One for.50 HB1 credit hours. ID# 0519-H.50-NHC6b.

Date of Original Release | August 2019
Course Termination Date | August 31, 2021
Contact Information | Center for Continuing Medical Education; (502) 446-5955 or [email protected]

State Resources

Listing of treatment centers / resources – FindHelpNowKY
Kentucky State Police assistance in finding a treatment center – Angel Initiative

Resources for Additional Study

Hendrée E. Jones, Ph.D., et. al., “Neonatal Abstinence Syndrome after Methadone or Buprenorphine Exposure”, New England Journal of Medicine 363: 24, pages 2320-2331.

Quentin Johnson, “Case Study: County-Level Responses to the Opioid Crisis in Northern Kentucky”, The Journal of Law, Medicine & Ethics, 46 (2018): 382-386.

Marc Galanter, “Combining medically assisted treatment and Twelve-Step programming: a perspective and Review”, The American Journal of Drug and Alcohol Abuse 2018, Vol. 44, No. 2, pages 151–159.

Hefei Wen, PhD, et. al., “Impact of Medicaid Expansion on Medicaid-covered Utilization of Buprenorphine for Opioid Use Disorder Treatment”, Medical Care , Volume 55, Number 4, April 2017, pages 336-341.

Harlan Matusow, M.A., et. al., “Medication assisted treatment in US drug courts: Results from a nationwide survey of availability, barriers and attitudes”, Journal of Substance Abuse Treatment 44 (2013) 473–480.